FORM OF SECURITIES PURCHASE AGREEMENTForm of Securities Purchase Agreement • January 23rd, 2020 • Neurotrope, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 22, 2020, between Neurotrope, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
ADVISORY CONSULTING AGREEMENTAdvisory Consulting Agreement • January 23rd, 2020 • Neurotrope, Inc. • Pharmaceutical preparations • New York
ADVISORY CONSULTING AGREEMENT (the “Agreement”) dated as of January 22, 2020 (the “Agreement”) by and between KATALYST SECURITIES LLC, a broker dealer registered with the Financial Industry Regulatory Authority (“FINRA”) (“Katalyst”) and NEUROTROPE, INC., a publicly traded company incorporated in the State of Nevada (the “Company”).
